A notable advancement in glucose management is emerging with the introduction of tirzepatide at a dosage of 45mg. This new formulation builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, and https://karimilne241650.is-blog.com/47674988/significant-introduction-tirzepatide-45mg-for-diabetes-control